Agilent Screening Drugs of Abuse by LC/MS

安捷伦 的其他说明书

• Agilent Mass-based fraction collection of compound libraries using the Agilent 1100 Series purification system
• Agilent Therapeutic Drug Monitoring by LC/MSD - Clozapine, an Example
• Agilent Protein Confirmation Using the LC/MSD TOF and the Agilent TOF Protein Confirmation Software
• Agilent Accurate Mass Measurement for Intact Proteins using ESI-oa-TOF
• Agilent Analysis of Organic Acids in Aqueous Samples
• Agilent Improved protein indentification: Off-line multidimensional LC/MS as an effective tool for proteomics research
• Agilent Tools and considerations to increase resolution of complex proteome samples by two-dimensional offline LC/MS
• Agilent Two-dimensional nano-LC/MS for complex proteomics application
• Agilent Proteome profiling of E.coli: Effect of heat-shock conditions on protein expression pattern
• Agilent Improved 2D nano LC/MS for proteomics applications - A comparison on yeast
• Agilent Assessing genomic DNA contaminations of total RNA isolated from kidney cells obtained by Laser Capture Microdissection using the Agilent RNA 6000 Pico assay
• Agilent Applications and features of the Agilent 1100 Series micro fraction collector
• Agilent Interpreting mRNA electropherograms
• Agilent HPLC Separation of Norethindrone and Mestranol Using Progesterone as an Internal Standard on Eclipse XDB-CN (L10 – USP) and Eclipse XDB-C8 (L7 – USP) Columns
• Agilent Eclipse XDB-CN Provides Excellent Selectivity and Resolution for Urea Pesticides

查看 安捷伦 全部说明书 →